Stock listing
Manzo Pharmaceuticals, Inc.
Selected listing: MNZO · OTC · USD · US
Manzo Pharmaceuticals, Inc. (OTC:MNZO), Health Technology. Latest release Feb 24, 2022: Shareholder Meeting.
- Ticker
- OTC:MNZO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Manzo Pharmaceuticals, Inc.
The company focuses on developing pharmaceutical products. Investors can find more information about its operations and market activities on its dedicated public company page.
Latest news from Manzo Pharmaceuticals, Inc.
Shareholder Meeting
February 23, 2022
Virtual Special Meeting
February 22, 2022
SEC Suspension of Trading
March 9, 2018
New Manzo Pharmaceuticals, Inc. Website
October 31, 2016
Manzo Pharmaceuticals, Inc announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.
July 29, 2016
Research Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc. company profile
View the public company page for Manzo Pharmaceuticals, Inc. on 6ix.
Manzo Pharmaceuticals, Inc. news
Read company news and market updates connected to Manzo Pharmaceuticals, Inc..
Manzo Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Manzo Pharmaceuticals, Inc..